p53 gene mutations are the most common genetic alterations in colon cancer (14), and tumor cells with p53 mutations can compete with the killing effect of suicide gene transformation prodrugs on tumor cells; thus, affecting the therapeutic effect of the suicide gene (15–18). This evidence concerns the gene TP53 and colonic neoplasm.